Novonesis (Novozymes A/S) engages in the era of biosolutions. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Bayer and Syngenta in Agriculture and DSM and Adisseo in Animal Health & Nutrition..
How did NVZMY's recent EPS compare to expectations?
The most recent EPS for Novozymes A/S is $0.44, not beating expectations of $0.48.
How did Novozymes A/S NVZMY's revenue perform in the last quarter?
Novozymes A/S revenue for the last quarter is $0.44
What is the revenue estimate for Novozymes A/S?
According to 4 of Wall street analyst, the revenue estimate of Novozymes A/S range from $1.15B to $1.06B
What's the earning quality score for Novozymes A/S?
Novozymes A/S has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Novozymes A/S report earnings?
Novozymes A/S next earnings report is expected in 2026-08-03
What are Novozymes A/S's expected earnings?
Novozymes A/S expected earnings is $1.12B, according to wall-street analysts.
Did Novozymes A/S beat earnings expectations?
Novozymes A/S recent earnings of $1.11B does not beat expectations.